Jennifer Bryant

(Former)

View graph of relations

Most downloaded publications

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
5 Jan 2019, In : The Lancet. 393, 10166, p. 51-60 10 p.

Research output: Contribution to journal › Article

130 downloads
The Clinical Utility of Cell-Free DNA Measurement in Differentiated Thyroid Cancer: A Systematic Review
Jennifer Bryant, Nikos Batis, Rachel Spruce, Christopher McCabe, Kristien Boelaert, Neil Sharma & Hisham Mehanna, 30 Apr 2018, In : Frontiers in Oncology. 8, APR, 132.

Research output: Contribution to journal › Article

84 downloads
Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma
Jennifer Bryant, Nikos Batis, Gordon Ryan, Jill Brooks, Andrew Southam, Nicholas Barnes, Jo Parish, Sally Roberts, Farhat Khanim, Rachel Spruce & Hisham Mehanna, 27 Aug 2019, In : OncoTarget. 10, 50, p. 5229-5244 16 p.

Research output: Contribution to journal › Article

48 downloads
Human Papillomavirus (HPV) vaccine effectiveness and potential herd immunity for reducing oncogenic oropharyngeal HPV16 prevalence in the UK: a cross-sectional study
Hisham Mehanna, Jennifer Bryant, Rachel Spruce, Nikos Batis, Oladejo Olaleye, Dec 2018, In : Clinical Infectious Diseases.

Research output: Contribution to journal › Article

16 downloads

Recent publications

Development and validation of a combined hypoxia and immune prognostic classifier for head and neck cancer
Jill Brooks, Albert Menezes Antao Nobre De Menezes, Lucinda Archer, Neeraj Lal, Rachel Spruce, Nikos Batis, Jennifer Bryant, Gordon Ryan, Steve Lee, Gary Middleton, Daniel Tennant & 7 others, Andrew Beggs, Jon Deeks, Jean-Baptiste Cazier, Benjamin Willcox & Hisham Mehanna, Sep 2019, In : Clinical Cancer Research. 25, 17, p. 5315-5328 15 p.

Research output: Contribution to journal › Article

Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma
Jennifer Bryant, Nikos Batis, Gordon Ryan, Jill Brooks, Andrew Southam, Nicholas Barnes, Jo Parish, Sally Roberts, Farhat Khanim, Rachel Spruce & Hisham Mehanna, 27 Aug 2019, In : OncoTarget. 10, 50, p. 5229-5244 16 p.

Research output: Contribution to journal › Article

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
5 Jan 2019, In : The Lancet. 393, 10166, p. 51-60 10 p.

Research output: Contribution to journal › Article

View all (7)